NLARx News
Rep. Cindy Rosenwald and NLARx Vindicated in Federal Court of Appeals Decision Issued Yesterday!
Read Decision
Federal Court Upholds New Hampshire Drug Marketing Restrictions MoreFederal Court Upholds Drug Privacy Law More |
In the States
NEW HAMPSHIRE: NH Prescription Privacy Law Upheld More
MASSACHUSETTS: State Cuts $10M from Biotech's Billion More
VERMONT: Secret Pharma Payments To Doctors Disclosed More
MINNESOTA: Minnesota Receives SCHIP Waiver More
MISSOURI: AG and Schering-Plough Reach $31 Million Settlement More
ARIZONA: CMS To Launch Personal Health Record Pilot for Medicare More
WISCONSIN: Primary Care Physician Shortage, Report Says More
TEXAS: Pharmacist Legislator in Tight Race as Legislative Control Hangs in the Balance More
OTHER STATES: Kaiser Daily Health Policy Report Highlights Health Care Proposals in Six States More |
Outrage of the Week
Pharma Execs: Cost Cutting Is Not A Top Priority More
|
Prices and Access to Healthcare
Scouting Drug Savings More
Baucus To Release Detailed Universal Health Care Plan Today More
Biotech Firms Fear Pricing Pressure from Obama More
Drugmaker Ads to Target Obama Idea More
U.S. Residents With Chronic Illnesses Face Medical Errors, Forgo Care Because of Cost More
OECD Study Asks Which Country Spends The Most On Meds? More
Crestor Study Could Result in Increasing Costs by $10B/yr More
Groups Call on Obama To Address Health Care in First 100 Days More
NEJM Perspectives Examine U.S. Primary Care System, Obama Health Care Proposal More
Medication Access and Vulnerable Populations: What's Changing More
|
Fraud and Abuse
Justice Dept Says Health Fraud Recoveries Top $1B In FY08 More
Ex-CEO Guilty in $1.9B Fraud Case More
Justice Dept & 35 States Probe Vytorin More
Justice Dept Investigates Vytorin Marketing, More Lawsuits Face Merck, Schering More
Judge Tosses RICO Lawsuit Against AstraZeneca More
|
Advertising and Marketing
Appeals Court Reverses Decision on Prescription Privacy More
DTC Ad Spending Will Decrease 9% in 2008 and 11% in 2009! More
DTC Ad Spending Is Down, And Falling Fast More
Will Fewer Sales Reps Lead to Higher Costs? More
AARP Orders Investigation Concerning Its Own Marketing More
Google Explains Why Drug Companies Fear the Web More
Merck Study Shows Promise for Gardasil in Boys More
J&J Gets Caught in a Sling Over Internet Motrin Ad More
Senate Committees Probe Johnson & Johnson More
Amgen Eyes Internet and Modest Sales Force to Launch Denosumab More
Glaxo Poised to Rejigger American Unit, Cut Sales Reps More
UK Regulator Reprimands Lilly For Cialis Marketing More
PhRMA To Launch Free-Market Ad Campaign; SEIU Pushes for Health Reform More
Drug Trade Group Starts Ads on Insuring Chronically Ill, Denies Salvo Against Price Controls More
|
Conflicts of Interest
MedPAC Adopts Recommendations To Improve Transparency of Financial Ties Between Industry, Physicians More
Grassley Urges NIH Crack Down on Undisclosed Conflicts More
Drug Industry Trade Secrets: Speaking Fees, Education Subsidies More
Brain Trust: Universities & Pharma Tighten Alliances More |
Pharma Watch
Amgen, Like Pfizer, Targets Biotechs With Ready Cash More
Industry Sales Outlook Decreasing More
Wyeth to Focus Research Efforts on Fewer Diseases More
Will Big Pharma really shift strategy? More
Novartis And The FDA Priority Review Voucher More
Merck's Heart Remains Steadfast in Hunt for Cardiovascular Drugs More
Pfizer & Sanofi-Aventis Abandon Obesity Drugs More
Pharma Bets Its Chips in Developing Countries More
Racing Down the Pyramid More
|
PBM Watch
Change to Win Launches Reform Initiative On CVS PBM Business More
Unions Highlight CVS' Alleged Improper Promotion of Costly Diabetes Treatment More
Express Scripts Reports New Threats Tied to Data Security Breach More
Express Scripts Offers $1M Rewards For Extortion More
Pharma Analyst: "PBM" Spells "Opportunity" More
Union Yes? More |
Medicare
Picking a Medicare Drug Plan More
Medicare Coverage Gap Vexes Patients, Survey Says More
Medicare Part D Sign-Up Brings Questions, Costs More
Most Medicare Beneficiaries Do Not Understand Part D 'Donut Hole' More
CMS Wants Connecticut To Make Sure Medicaid Beneficiaries Know They Do Not Have To Switch Insurers More
Court Bars CMS Policy Pegging Payment to Effectiveness More
CMS Slow to Audit Part D Plans' Drug Prices More
Higher Prices, Fewer Drug Choices for Medicare Beneficiaries More
New, Updated Resources on Medicare Prescription Drug Benefit More
Medicare Drug Benefit Open Enrollment News More
Rep. Stark Outlines Subcommittee Agenda More
CMS Issues Revised Compensation Guidelines for Medicare Sales Agents More
|
Medicaid
Obama Calls for Swift Action; Congress Unlikely To Pass Economic Stimulus Package With Medicaid Funds More
Pharmacy Groups Amend Complaint Against Medicaid Rule More
Kaiser Daily Health Policy Report Highlights News About State Budgets More
|
Patents and Generics
Congressional Study Of Reverse Payment Settlements on Market More
Eyeing Generics, Cephalon Hikes Price on Provigil More
How a Drug Maker Tries to Outwit Generics More
India's Drugmakers Fear Heat From The FDA More
Medco CEO: Generic Biotech Bill Likely to Pass Congress in 2009 More
|
Safety and Clinical Trials
Congress Investigates Alleged Coercion in Medical Device Approval Process More
Use of Antipsychotics in Children Is Criticized More
Congress Probes 'Corrupted' FDA Device Approvals More
Chantix, Heparin Top List of Adverse Events More
Brand-Name Drugmakers Liable To Patients Taking Generics More
FDA Reports Side Effects Linked to Wrinkle Fillers More
FDA Asks if Pain Pill Is Tamper-Proof More
Osteoporosis Drugs Do Not Pose Heart Risk: FDA More
Sedative Could Be Deadly in People With Seizures More
Study Raises Concerns on Mixing Plavix and Heartburn Drugs More
Painkiller Risk Found for Heart Patients More
Actavis Sued by U.S. Regulators to Shut Heart Drug Manufacturer More
Will Personalized Medicine Lead to FDA Changes? More
Study Finds Crestor Can Reduce Risk for Cardiovascular Events More
AstraZeneca CEO Downplays Jupiter's Effect on Crestor Sales More
San Francisco Court Revives Suit vs. Wyeth Over Generic More
FDA: No Link Between Bone Drugs and Heart Problems More
FDA Sends in Federal Marshals to Seize Tainted Heparin More
Feds Send Mixed Message to China More
Merck's Gardasil Should Not Be Mandatory: Report More
|
Inside the FDA
HHS Secretary, FDA Commissioner in Obama Administration Discussed More
Woodcock Gains Support From Drugmakers for FDA Top Job More
Peter Rost Gets Serious About Becoming FDA Commissioner More |
Integrity in Science
Senators Question FDA Over PR Contract Bidding More
Defamation Suit Seeks to Silence Critical Research More
|
Editorials and Opinions
Supreme Court Case on Drug Safety, Federal Pre-Emption More
Tragic Injury Wasn't the Drug's Fault More
Health Care Savings Needed To Improve Retirement System More
Supreme Court Should Rule in Favor of Plaintiff in Pre-Emption Case More
Clarification of Medicaid Outpatient Hospital Benefit Might Have 'Severe' Effects More |
